beyond resolution of clinical illness. Risk factors for measles mortality include lack of prior measles vaccination [6] , young age [7] , female sex [8] , and malnutrition [9] , particularly vitamin A deficiency [10] . Few studies have investigated risk factors for measles mortality in regions of high HIV-1 prevalence. HIV-1 infection can impair both cellular and humoral immunity by reducing the number of CD4 + T lymphocytes and would be expected to increase mortality in children coinfected with measles virus (MV). Most reports of increased mortality among HIV-1-infected children with measles are based on small numbers of children in the United States [11] . We previously described the clinical features and risk factors for morbidity and mortality in hospitalized Zambian children with measles [12] . Although this was the largest reported series of HIV-1-infected children hospitalized with confirmed measles, the number of in-hospital deaths was small (23 deaths), and we did not observe a significant difference in the proportion of HIV-1-infected (5.4%) and -uninfected (4%) children who died in the hospital. We extended enrollment for 2.75 years and re-examined risk factors for in-hospital measles mortality in this population with high HIV-1 prevalence.
METHODS
Children hospitalized at the University Teaching Hospital (Lusaka, Zambia) between January 1998 and July 2003 with the clinical diagnosis of measles were prospectively enrolled. From February 2002 through March 2003, enrollment was limited to children residing in 3 townships of Lusaka, in conjunction with a study of the immunogenicity of measles vaccine [13] . An analysis of a subgroup of these children hospitalized with suspected measles between January 1998 and October 2000 was published elsewhere [12] . Measles vaccine is routinely administered in Zambia at age 9 months, and the standard practice was to administer vitamin A to all children with measles. Zambia conducted a mass measles vaccination campaign in June 2003, which was followed by a marked decrease in the incidence of measles [14] . Children were usually enrolled on the day after admission to the measles ward. Those who were severely ill or who died within hours after admission were unlikely to be enrolled. Written informed consent was obtained from the parents or guardians of the children studied. The research was approved by the institutional review boards at the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD), the London School of Hygiene and Tropical Medicine (London, United Kingdom), and the University Teaching Hospital (Lusaka, Zambia).
Data collection and laboratory assays were performed as described elsewhere [12] . A study nurse or clinical officer administered a questionnaire and performed a physical examination at enrollment, shortly after patient admission to the hospital. Children were considered to have been vaccinated against measles if this was documented on the child's under-5 health card or if reported by the child's caregiver. Blood specimens were collected in EDTA tubes. MV infection was confirmed by detection of MV-specific IgM antibodies in plasma by EIA (Wampole Laboratories). MV infection was excluded if 2 plasma samples collected at study entry and at discharge or follow-up had undetectable IgM antibodies to MV. Children whose single plasma sample obtained at study entry had undetectable IgM antibodies to MV were classified as having unconfirmed measles. Plasma specimens were tested for antibody to HIV by EIA (Organon Tecknika), and those that yielded positive results were assayed for HIV-1 RNA (Amplicor HIV-1 Monitor v. 1.5; Roche Molecular Systems). Children were classified as being HIV-1 infected if HIV-1 RNA was detected in plasma.
Categorical variables were compared using the x 2 test. Multivariable logistic regression was used to identify predictors of measles mortality, as well as to assess interactions and to control for potential confounders. Continuous variables were compared using the nonparametric Kruskal-Wallis test. Exact binomial 95% CIs were calculated for proportions. Statistical analyses were performed using STATA Release 9 statistical software (Stata).
RESULTS
Between January 1998 and July 2003, 1474 children who were hospitalized with clinically diagnosed measles were enrolled in the study. MV infection was confirmed in 1270 children (86%) and excluded in 77 children (5%). The remaining 127 children (9%) had unconfirmed measles (a single negative test for anti-MV IgM antibodies at study entry) and were excluded from analyses of risk factors for measles mortality. HIV-1 infection status was determined for 1227 children (97%) with confirmed measles, 189 (15%) of whom were coinfected with HIV-1. HIV-1-infected children were more likely to have unconfirmed measles (18% of all HIV-1-infected children) than were HIV-1-uninfected children (8% of all HIV-1-uninfected children;
).
The median age of HIV-1-infected children was 12 months (range, 2-215 months), compared with 14 months (range, 1-192 months) for HIV-1-uninfected children ( ). Almost P p .3 one-third of the HIV-1-infected children were aged !9 months, the age of routine measles vaccination, compared with onefourth of the uninfected children ( ) (table 1) . The pro-P p .07 portion of HIV-1-infected children who were aged !6 months (9%) was almost twice that of HIV-1-uninfected children (5%;
), although the number of children in this age group P p .05 was small (table 1) . Mothers of HIV-1-infected children were more likely to have a higher level of education (18 years) than were mothers of HIV-1-uninfected children (table 1) . Information on measles vaccination status was available for 98% of the HIV-1-infected children and 95% of the HIV-1-uninfected children (
). Among children aged у9 months, 60% of P p .09 HIV-infected and 47% of HIV-1-uninfected children were considered to have received measles vaccine ( ) (table 1) , P p .008 with documentation on the under-5 card available for 49% of vaccinated children in each group.
Among the 1474 enrolled children, 6.7% died in the hospital. There were 68 deaths during hospitalization among the 1227 children with confirmed measles and known HIV-1 infection status, corresponding to a measles case fatality ratio (CFR) of 5.5%. Death occurred in 23 HIV-1-infected children (12.2%) and 45 HIV-1-uninfected children (4.3%; ) (table 2) .
In unadjusted analyses, HIV-1 infection (OR, 3.2; 95% CI, 1.9-5.5), р8 years of maternal education (OR, 2.2; 95% CI, 1.1-4.4), and presence of a desquamating rash (OR, 1.9; 95% CI, 1.2-3.2) were associated with in-hospital mortality (table 2) . We did not observe an increased risk of in-hospital mortality among girls, children aged !9 months, or unvaccinated children (table 2) . When analysis was restricted to those children with documented measles vaccination on the under-5 health card, the CFR for children with a history of measles vaccination (6.4%) was similar to that of unvaccinated children (5.8%;
). P p .74
In a logistic regression model based on 1035 children, HIV-1 infection remained associated with measles mortality (OR, 2.5; 95% CI, 1.4-4.5) after adjustment for age, sex, and measles vaccination status (table 2) . Eight or fewer years of maternal education (OR, 2.4; 95% CI, 1.2-4.8) and presence of a desquamating rash (OR, 2.2; 95% CI, 1.3-3.7) were additional predictors of in-hospital measles mortality in the adjusted analysis (table 2) . There was no evidence of interaction between sex and measles vaccination status ( ), HIV-1 infection P p .3 and sex ( ), HIV-1 infection and measles vaccination P p .5 status ( ), or HIV-1 infection and maternal educational P p .6 level ( ), and these interaction terms were not retained P p .5 in the model.
DISCUSSION
HIV-1-infected children with confirmed measles had a high in-hospital CFR, 2.5 times higher than that among HIV-1-uninfected children. The actual in-hospital CFRs could be higher because we were less likely to enroll children who were severely ill or who died within hours after arriving at the hospital. In contrast, we only included children hospitalized with measles, and the estimated CFR does not reflect mortality among children with measles in the community. Some children in the community may have had mild measles, not sought medical attention, or died at home. We do not have information on children with measles in the community to assess the biases introduced by studying hospitalized children.
A report from the Centers for Disease Control and Prevention first highlighted the unusual and severe clinical manifestations of measles in 5 HIV-1-infected children (a sixth child was reported but was subsequently found not to be HIV-1 infected) [15] . Additional case reports from the United States confirmed the unusual clinical manifestations and severity of measles in HIV-1-infected persons, with a CFR of 32% among 19 HIV-1-infected children with measles [11] . These case series were subject to reporting biases and overestimation of the CFR, although they were consistent with reports from sub-Saharan Africa. In the former Zaire, the CFRs among 16 HIV-seropositive and 298 -seronegative children hospitalized with measles were high but similar (31%, compared with 28%, respectively) [16] . Another group of investigators in Lusaka, Zambia, reported that the measles CFR for HIV-seropositive children aged 9-59 months was significantly higher (28%) than for HIVseronegative children (8.3%) [17] , although the investigators did not distinguish HIV-1-infected from HIV-seropositive children. Ours is, to our knowledge, the largest prospective study of measles in a region of high HIV-1 prevalence in which infection with both MV and HIV-1 was laboratory confirmed.
HIV-1-infected children hospitalized with measles differed from HIV-1-uninfected children in several important characteristics. HIV-1-infected children with measles were more likely to be younger than 6 and 9 months (the age of routine measles vaccination), compared with HIV-1-uninfected children, consistent with our previous findings [12] and with the observation that infants born to HIV-1-infected women lose passively acquired, protective maternal antibodies at an earlier age [18, 19] . HIV-1-infected children also were more likely to have a history of measles vaccination. We previously reported that HIV-1-infected children are less likely to receive routine childhood vaccines than are HIV-1-uninfected children [20] , so the difference in vaccination status among children with measles suggests lower vaccine efficacy among HIV-1-infected children, consistent with their observed loss of protective antibody levels after measles vaccination [13] . The fact that HIV-1-infected children were more likely to have unconfirmed measles (undetectable measles IgM antibodies in a single plasma sample obtained at study entry) suggests that these children may have either delayed development of an IgM antibody response or are prone to infection with other pathogens that present with fever and rash and that clinically resemble measles. The rash of measles is a manifestation of the host cellular immune response [21] and can be absent in persons with measles and advanced HIV-1 infection [15] . We found that the presence of a desquamating rash was associated with increased mortality from measles. Desquamating rash following measles was first described in malnourished children [9] . Interestingly, rhesus monkeys depleted of CD8 + T lymphocytes developed a desquamating rash after challenge with wild-type MV that was associated with higher and more prolonged viremia [22] . It is not known whether the desquamating rash in children with measles is associated with an altered immunological response or with a higher level of viremia.
The increased risk of mortality among hospitalized HIV-1-infected children with measles, as well the increased risk among malnourished children [9] , could be a consequence of impaired cellular immune responses. Evidence of the importance of cellular immunity to MV clearance in humans is demonstrated by the ability of children with agammaglobulinemia to fully recover from measles, whereas children with severe defects in T lymphocyte function often develop severe or fatal disease [23] . MV-specific CD8 + T lymphocyte responses have not been measured in HIV-1-infected children, although plasma levels of immune activation markers [24] and cell surface markers of T lymphocyte activation were elevated in HIV-1-infected children with measles [25] . Further studies are needed to characterize MV-specific cellular immune responses among HIV-1-infected children.
Children whose mothers had р8 years of education were at increased risk of in-hospital mortality from measles. Several studies have found evidence of an inverse association between maternal education and child mortality in sub-Saharan Africa [26] [27] [28] , although the exact mechanisms through which maternal education impacts child mortality are not clear. We did not have sufficient information to formally explore this association, but higher levels of maternal education could be associated with better nutritional status and health-seeking behavior. We did not find an association between sex and measles mortality, although excess measles mortality in females was described in a pooled analysis of data from 78 countries between 1950 and 1989 [8] . However, the pooled analysis ex-cluded many countries within sub-Saharan Africa because of a paucity of data and found the lowest risk of excess female mortality in children aged !5 years.
As reported, in a subset of these hospitalized children with measles, malnutrition was more common among HIV-1-infected than among -uninfected children [12] . Stunting was observed among 61% of HIV-1-infected children, compared with 44% of -uninfected children ( ), and wasting was P p .01 observed among 20% of HIV-1-infected children, compared with 10% of -uninfected children ( ) [12] . However, P p .005 nutritional status was not measured for all children in the extended study. Undernutrition would lie on the causal pathway between HIV-1 infection and measles mortality; therefore, adjustment for nutritional status should not be made when assessing HIV-1 infection as a risk factor for measles mortality.
Remarkable progress in reducing measles incidence and mortality has been made in parts of sub-Saharan Africa as a consequence of increasing measles vaccine coverage, provision of a second opportunity for measles vaccination through supplementary immunization activities, improved case management, and enhanced surveillance, with laboratory confirmation of measles cases [29] . High levels of population immunity can provide indirect protection to susceptible HIV-1-infected children. Increased mortality among HIV-1-infected children with measles is further evidence that greater efforts are necessary to reduce MV transmission in regions of high HIV-1 prevalence, to achieve the Millennium Development Goals and to reduce global measles-related deaths by 90% by 2010.
